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Introduction
The ECM is an important source of developmental cues. ECM 
proteins can stimulate cell migration (Giannelli et al., 1997), 
regulate the availability of signaling molecules (Kirkpatrick 
et al., 2004; Kreuger et al., 2004), and promote proliferation 
and differentiation (Nikolova et al., 2006). Fibulin-1 is a broadly 
conserved ECM protein (Timpl et al., 2003). However, func-
tional analyses of this conserved class of ECM proteins remain 
in their infancy.
The Caenorhabditis elegans FIBULIN-1 (FBL-1) protein 
is homologous to mammalian Fibulin-1 (Barth et al., 1998). 
Both proteins share a common domain architecture with an 
N-terminal signal sequence, three anaphylatoxin (AT) repeats, 
nine EGF-like repeats, and an alternatively spliced fi  bulin-type 
(FIB) C-terminal domain (Fig. 1 A). The AT domain is related 
to infl  ammatory peptides that are released during activation of 
the complement system (Kohl, 2001). EGF-like repeats often 
mediate protein–protein interactions and can function as sig-
naling ligands (Prigent and Lemoine, 1992). The mammalian 
Fibulin-1 EGF domain is required for binding to other base-
ment membrane proteins, including nidogen-1 and fi  bronectin 
(Sasaki et al., 1995; Tran et al., 1997). In C. elegans, the second 
EGF repeat is alternatively spliced, generating a choice between 
a canonical EGF repeat (EGF2C) and a divergent EGF repeat 
(EGF2D) with a 39-aa insertion. The FIB domain defi  nes the 
fi  bulin family of proteins, which includes fi  ve proteins in mam-
mals but only FBL-1 in C. elegans. Mammalian and nematode 
Fibulin-1 homologues share the C and D alternatively spliced 
FIB domains (Barth et al., 1998). The FIB domain may control 
the specifi  city of physical interactions because mammalian 
  Fibulin-1C has a 30-fold higher affi  nity than Fibulin-1D for 
  nidogen-1 (Sasaki et al., 1995).
Targeted deletion of mouse fi  bulin-1 has revealed a key 
role in development. fi  bulin-1 knockout mice have capillary 
  defects, resulting in extensive hemorrhaging and perinatal death 
(Kostka et al., 2001). FBL-1 deregulation may lead to human 
disease. A balanced translocation that alters the ratio of the 
C and D forms of FBL-1 is linked to polydactyly, implicating 
FBL-1 in digit development (Debeer et al., 2002). FBL-1 may 
also play a role in cancer metastasis. The overexpression of 
FBL-1D but not -1C reduces the invasiveness of human fi  bro-
sarcoma cells in immunodefi  cient mice (Qing et al., 1997). 
Thus, it is likely that alternative splicing generates FBL-1 iso-
forms with specialized biological activities.
fbl-1 has multiple roles in C. elegans development. fbl-1 
mutants are sterile with expanded somatic gonads (Hesselson 
et al., 2004; Kubota et al., 2004; Muriel et al., 2005), which 
is reminiscent of the enlarged capillaries found in fi  bulin-1 
Growth control by EGF repeats of the C. elegans 
Fibulin-1C isoform
Daniel Hesselson
1 and Judith Kimble
1,2,3
1Department of Genetics, 
2Department of Biochemistry, and 
3Howard Hughes Medical Institute, University of Wisconsin-Madison, Madison, WI 53706
  F
ibulin is a broadly conserved component of the 
  extracellular matrix (ECM). Previous studies have 
shown that Caenorhabditis elegans FIBULIN-1 
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both epidermal growth factor (EGF) and ﬁ  bulin-type C 
domains, is responsible for constraining gonadal width, 
but a much smaller fragment containing only two com-
plete EGF repeats (EGF1-2C+) is critical for develop-
mental growth. We suggest that the larger fragment 
serves a scaffolding function to stabilize the basement 
membrane and that the smaller fragment provides a 
regulatory function at the cell surface or within the ECM 
to control growth.
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knockout mice. fbl-1 mutants are smaller than wild-type ani-
mals in overall body size and progress through larval stages at a 
slower rate than wild-type animals. These defects may refl  ect 
structural abnormalities in the feeding and digestive organs, the 
pharynx, and intestine, respectively (Muriel et al., 2005). The 
fbl-1 gene is expressed in the intestine (Hesselson et al., 2004; 
Kubota et al., 2004; Muriel et al., 2005), whereas gon-1 is ex-
pressed in both body wall muscle and distal tip cells (Blelloch 
and Kimble, 1999). However, both proteins are secreted: FBL-1C 
localizes to the gonad, pharynx, and intestine, whereas FBL-1D 
is associated with neuronal cells and fl  exible fi  bers (Hesselson 
et al., 2004; Kubota et al., 2004; Muriel et al., 2005). These dif-
ferent patterns of localization in C. elegans are consistent with 
the distinct binding properties of the two mammalian isoforms 
in vitro (Sasaki et al., 1995).
We previously described an antagonistic interaction be-
tween fbl-1 and gon-1/ADAMTS (a secreted a disintegrin and 
metalloprotease with thrombospondin repeats protein;  Hesselson 
et al., 2004). GON-1 is required for the migration of gonadal 
distal tip cells (Blelloch and Kimble, 1999). Fibulin also affects 
distal tip cell migration; fbl-1 mutations can suppress the gon-1 
migration defect (Hesselson et al., 2004). Furthermore, gon-1 
mutations suppress the distended gonad of fbl-1 mutants, revealing 
an antagonistic relationship between these two regulators.
In this study, we report an unexpected synthetic lethality 
between gon-1 and fbl-1 null mutants. Using FBL-1 transgenes, 
we have defi  ned the alternatively spliced EGF2C repeat as 
being critical for both larval progression in fbl-1 gon-1 double 
mutants and normal growth in fbl-1 single mutants. Indeed, 
a small fragment including EGF2C provides these essential 
FBL-1 functions. In contrast, most of the FBL-1C protein is 
  required for gonadogenesis, revealing context-specifi  c require-
ments for different portions of FBL-1C in larval development.
Results and discussion
Isolation and phenotypic analysis 
of a fbl-1 null allele
The fbl-1(q750) deletion allele removes genomic DNA encoding 
the C-terminal half of the FBL-1 protein (Hesselson et al., 
2004). Therefore, this deletion encodes the N-terminal half of 
FBL-1 and may not be a null allele. To isolate a null allele, we 
used primers fl  anking the 5′ end of the fbl-1 gene to isolate 
  fbl-1(q771), a 682-bp deletion that removes the N terminus of 
the fbl-1 locus, including 141 bp of the 5′ fl  anking sequence and 
the predicted transcriptional start site (Fig. 1 A). By RT-PCR 
using primers located 3′ of the fbl-1(q771) deletion and 5′ of 
the fbl-1(q750) deletion, products of the expected sizes were 
detected in wild type and fbl-1(q750) but not in fbl-1(q771) 
(see Materials and methods section fbl-1 transcript analysis). 
We conclude that the fbl-1(q771) allele does not produce an 
abundant mRNA product and that it is likely a null allele.
The phenotypes of fbl-1(q771) and fbl-1(q750) homo-
zygotes were compared. fbl-1(q771) mutants have a reduced 
growth rate (Fig. 1 B), small size (Fig. 1 C), and uncoordinated 
kinking movement, which are defects previously observed in 
fbl-1(q750) mutants (Hesselson et al., 2004). Similarly, both 
fbl-1(q771) and fbl-1(q750) animals are sterile and have 
an   expanded gonad compared with wild type (Fig. 1, D–F). 
Therefore, the fbl-1(q771) and fbl-1(q750) single mutants have 
similar phenotypes.
Synthetic larval arrest in fbl-1(q771) 
gon-1(0) double mutants
Because fbl-1(q771) and fbl-1(q750) single mutants have similar 
phenotypes, we predicted that these alleles would also have 
similar genetic interactions. The fbl-1(q750) mutation sup-
presses migration defects of gon-1(0), and gon-1(0) suppresses 
fbl-1(q750) gonadal expansion defects, revealing an antagonistic 
relationship between these two regulators (Hesselson et al., 
2004). Surprisingly, fbl-1(q771) gon-1(0) double mutants ar-
rested as young larvae (Fig. 2, compare A with D), whereas the 
fbl-1(q750) gon-1(0) double mutants grew to adulthood, as do 
the respective single mutants (Fig. 2, B and C). The fbl-1(q771) 
gon-1(0) larval arrest is not caused by extraneous linked 
Figure 1. A  fbl-1 null allele. (A, top) fbl-1 gene modiﬁ  ed from Muriel et al. 
(2005). Alternative splicing of exons C and D generates FBL-1C and -1D. 
(bottom) FBL-1C and -1D proteins. (B) Duration of larval development, mea-
sured in hours from L1 to mid-L4. n = 25. (C) Adult body size measured in 
micrometers squared. n = 10. (B and C) Data are given as the mean ± 
SEM (error bars). (D–F) Mid-L4 larvae; genotypes are given in the ﬁ  gure. 
Lines indicate the gonadal width. Arrowheads point to the distal ends of 
gonads. Bars, 20 μm.GROWTH CONTROL BY FIBULIN EGF REPEATS • HESSELSON AND KIMBLE 219
  mutations because an independently derived deletion allele, 
  fbl-1(tk45), had a similar synthetic larval arrest with gon-1(0) 
(Fig. 2 E). The synthetic interaction is specifi  c because the de-
pletion of nidogen or the ADAM protease MIG-17 did not cause 
larval arrest in fbl-1(q771) nid-1(0) and fbl-1(q771) mig-17(0) 
double mutants (unpublished data). Therefore, both fbl-1 and 
gon-1 affect progression through larval development.
Next, we examined the stage and possible causes of larval 
arrest in fbl-1(q771) gon-1(0) double mutants. Double mutants 
completed embryogenesis and proceeded to the second larval 
stage. Details of this characterization are described in Materials 
and methods (see Phenotype characterization). No defect in 
pharyngeal function was found, and pharyngeal size was com-
parable in fbl-1(q771) gon-1(0) double mutants and wild type 
(Fig. 2, G and H). Intestinal morphology was altered in 
the double mutant, but its lumen was not obstructed (Fig. 2, 
I and J; and Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200608061/DC1). Therefore, the cause of larval arrest 
remains unknown. Regardless, we conclude that fbl-1 and gon-1
are synthetically lethal, which suggests a redundancy of these 
two regulators.
FBL-1 domains required 
for larval progression
The synthetic lethality of fbl-1(q771) gon-1(0) double mutants 
provided a simple assay for analyzing the function of individual 
FBL-1 domains. Specifi  cally, we generated a series of trans-
genes in which the fbl-1 5′ fl  anking sequence was used to drive 
the expression of FBL-1 fragments tagged with VENUS. For 
each transgene, we scored double mutants for progression to 
adulthood (Fig. 3). The expression of all transgenes was verifi  ed 
by the visualization of VENUS using confocal microscopy, and 
most were also verifi  ed by the detection of proteins in Western 
blots (see Figs. 5 and S1).
Normally, the fbl-1 gene produces alternatively spliced 
mRNAs encoding two distinct proteins, FBL-1C and -1D (Fig. 1 A). 
The full fbl-1 gene with VENUS inserted at the N terminus 
  rescued larval arrest of fbl-1(q771) gon-1(0) double mutants 
(Fig. 3 A). The animals grew to adulthood and had a gon-1(0) 
phenotype. To learn which alternatively spliced transcript was 
responsible for rescue, we expressed VENUS::FBL-1C and -1D 
transgenes in fbl-1(q771) gon-1(0) double mutants. VENUS::
FBL-1C rescued larval arrest, whereas VENUS::FBL-1D did 
not (Fig. 3 A).
To defi   ne the essential domains within FBL-1C, we 
  generated a set of transgenes that were deleted for individual 
domains (Fig. 3 B). Rescue was observed with transgenes 
Figure 2.  Synthetic lethality of fbl-1(0) gon-1(0) double mutants. 
(A–J) Anterior to left; genotypes are given in the ﬁ  gure. (A–F) Body size 
comparisons of young adults (A–C) and double mutants (D and E) 72 h 
  after L1. (F) Young adult rescued by EGF1-2C+ fragment. (G and H) Phar-
ynx comparison of wild-type L4 (G) and double mutants at 48 h after 
L1 (H). Lines indicate anterior and posterior bulbs. (I and J) Intestine 
  comparison of wild-type L4 (I) and double mutants (J) 48 h after L1. Arrow-
heads indicate gut lumen width; arrows point to bacteria in the lumen. Gut 
granules are depleted in the double mutant; compare boxed regions.
Figure 3.  EGF2C is critical for the rescue of fbl-1(q771) gon-1(0) larval 
arrest. (A–E, left) Protein diagrams show FBL-1 domains in each transgene. 
Each construct was expressed using 4.5 kb of the fbl-1 5 ′ ﬂ   anking 
  sequence. Domains depicted as in Fig. 1. VENUS, green oval. (right) n = 25 
for each transgene. Gonads were variable in rescued animals.JCB • VOLUME 175 • NUMBER 2 • 2006  220
  deleted for either AT or FIB domains, but deletion of the EGF 
domain abolished rescue (Fig. 3 B). Furthermore, the EGF 
  domain was suffi  cient for rescue: VENUS::EGF1-9, which en-
codes all nine EGF repeats but no other FBL-1 domain, was 
suffi  cient for rescue (Fig. 3 B). Therefore, the EGF repeats are 
both necessary and suffi  cient for rescue.
The EGF domains from the rescuing VENUS::FBL-1C 
transgene and the nonrescuing VENUS::FBL-1D transgene 
  differ in the second EGF repeat as a result of the alternative 
splicing of exons 5C and 5D (Fig. 1 A). To ask whether EGF2C 
is necessary for rescue, we swapped EGF2 between the two 
  isoforms to generate VENUS::EGF2D/FIBC and VENUS::
EGF2C/FIBD (Fig. 3 C). Only VENUS::EGF2C/FIBD was ca-
pable of rescue, demonstrating that alternatively spliced EGF2 
repeats have different functions (Fig. 3 C).
Because EGF2C is required for rescue, we tested fragments 
of the EGF domain to defi  ne a minimal rescuing fragment, 
 VENUS::EGF1-2C+, which contained EGF repeats 1, 2C, and 
part of EGF3 (Figs. 2 F and 3 D). For simplicity, we dub this 
fragment EGF1-2C+. Removal of either EGF1 or the remain-
der of EGF3 from EGF1-2C+ eliminated rescue (Fig. 3 D). 
  Either the single EGF2C requires the fl  anking sequence for cor-
rect folding/secretion or additional features within EGF1 and 
EGF3 contribute to rescue. In an attempt to distinguish between 
these possibilities, we placed EGF2C into the C-terminal half of 
the EGF domain, but this transgene had no rescuing activity 
(Fig. 3 E). The simplest explanation is that some additional fea-
tures within the minimal EGF1-2C+ fragment are required for 
FBL-1C function. Indeed, the EGF1-2C+ fragment contains 
residues that affect FBL-1 function and localization in other 
  developmental contexts (Kubota et al., 2004). Alternatively, 
the C-terminal half of FBL-1 may poison the biological activity 
of EGF2C.
Rescue of fbl-1 single mutant defects 
by deletion transgenes
To learn whether the EGF domain of FBL-1C also functions in 
the presence of wild-type GON-1, we scored VENUS-tagged 
FBL-1 transgenes for rescue of both the slow growth defect and 
small body size of fbl-1(q771) single mutants. All constructs 
that rescued the larval arrest of fbl-1(q771) gon-1(0) double 
mutants also rescued the fbl-1(q771) single mutant phenotypes 
(Fig. 4, A and B). Indeed, the same minimal EGF1-2C+ frag-
ment rescued both the development rate and body size (Fig. 4, 
A and B).
Because  fbl-1(q771) single mutants are sterile and have 
a distended gonad, we also measured gonadal width and fertility 
in the transgenic animals. In contrast to the rescue of growth and 
body size, both the EGF domain of FBL-1C and the FIBC domain 
were required for the rescue of gonadal width (Fig. 4 C). Indeed, 
most EGF repeats of FBL-1C are likely required for the control of 
gonadal width because deletion from the larger fragment of either 
the four N-terminal repeats or four C-terminal repeats abolished 
rescue (unpublished data). The AT domain was dispensable (Fig. 
4 C). We conclude that FBL-1 has different molecular functions 
in its controls of larval growth and organ width.
VENUS::FBL-1 localization
Full-length VENUS::FBL-1C localizes to pharyngeal and go-
nadal basal laminas (Fig. 5 A, gonad not depicted; Hesselson 
et al., 2004; Kubota et al., 2004; Muriel et al., 2005). However, 
the localization of individual domains had not been assayed. We 
found that transgenes containing either EGF2C or FIBC local-
ized to both pharyngeal and gonadal basal laminae (Fig. 5, A, F, 
L, O, and R; Fig. S1; and not depicted). In contrast, VENUS::
FBL-1D did not localize to either basal lamina (Fig. 5 I; Kubota 
et al., 2004; Muriel et al., 2005). Importantly, the rescue of 
  gonadal width required both the EGF domain of FIB-1C and 
the FIBC domain (Fig. 4 C), but each of these domains was 
 individually  suffi  cient for localization. Furthermore, EGF1-2C+ 
failed to rescue gonadal width but was localized to the gonadal 
basal lamina. We conclude that the localization of FBL-1 frag-
ments to the basal lamina is not suffi  cient for function.
Conclusions
This study focuses on the C. elegans FBL-1 ECM protein and 
its control of two biological processes: organ width and devel-
opmental growth. In fbl-1 null mutants, the normally slender 
gonad becomes distended and misshapen, an effect fi  rst seen in 
L4 larvae (Hesselson et al., 2004; Kubota et al., 2004; Muriel 
et al., 2005). The developmental defect in growth was mild in 
Figure 4. Rescue  of  fbl-1(q771) defects. (A–C) All tests performed in 
wild-type (N2) or fbl-1(q771) single mutants carrying indicated transgene. 
(A) Duration of larval development measured in hours from synchronized 
L1 to mid-L4. n = 25 animals for each strain. (B) Adult body size 24 h after 
mid-L4. n = 10 animals for each strain. (A and B) Mean ± SEM (error bars). 
*, P < 0.001 by t test. (C) Gonadal width and fertility. n = 20 animals for 
each strain.GROWTH CONTROL BY FIBULIN EGF REPEATS • HESSELSON AND KIMBLE 221
fbl-1 single mutants but severe in fbl-1(0) gon-1(0) double mu-
tants, which arrest as L2 larvae. Using transgenic assays, we 
found that most of the FBL-1C protein, including both EGF and 
FIBC domains, is required for the control of organ width, but 
only a few EGF repeats are responsible for growth. Therefore, 
FBL-1C is likely to affect organ width and larval growth by 
separate molecular mechanisms.
Structural abnormalities in the basal lamina are likely to 
cause organ distension in fbl-1 null mutants. Overexpression of 
the C. elegans homologue of collagen XVIII, which is called 
CLE-1, rescues the gonadal defect of fbl-1 mutants (Muriel 
et al., 2006). Therefore, extra CLE-1 compensates for the loss 
of FBL-1, suggesting a similar role for these two conserved 
ECM proteins in the integrity of the basal lamina. In mammals, 
the EGF and FIBC domains of Fibulin-1 contain multiple bind-
ing sites for a variety of ECM molecules, including nidogen 
(Timpl et al., 2003). Both EGF and FIBC domains are needed 
for FBL-1C control of gonadal width. Therefore, FBL-1C is 
likely to control organ width by providing a scaffold that stabi-
lizes ECM assembly within the gonadal basal lamina.
Major structural abnormalities in the basal lamina do not 
appear to cause the developmental growth defects of fbl-1 single 
mutants or fbl-1 gon-1 double mutants. Instead, a fragment con-
taining only EGF1, EGF2C, and part of EGF3 controls the nor-
mal rate of larval growth and correct body size. We suggest that 
EGF2C or the EGF1-2C+ fragment may control growth as a 
signaling ligand. One precedent for this idea is TGF-α, which 
contains a single EGF repeat that binds to and signals through 
EGF receptors (Massague, 1983). An alternative possibility is 
that the EGF1-2C+ fragment antagonizes interactions within 
the ECM and, thereby, permits remodeling of the basal lamina 
that is critical for growth.
The  fbl-1(0) gon-1(0) synthetic lethality suggests that 
FBL-1 and the GON-1 secreted metalloprotease act redundantly 
to promote larval progression, which is an idea that contrasts 
with the antagonistic activities of FBL-1 and GON-1 during 
  gonadogenesis (Hesselson et al., 2004). Perhaps these distinct 
relationships can be explained by the two different functions of 
FBL-1C. For example, in the control of gonadal width, FBL-1C 
might stabilize the ECM, whereas the GON-1 protease pro-
motes ECM breakdown and remodeling. In contrast, in the con-
trol of developmental growth, EGF1-2C+ and GON-1 might 
produce redundant signals.
The use of an alternatively spliced EGF repeat may be 
  relevant to mammalian fi  bulin. Mammals contain fi  ve genes 
 encoding  fi  bulin-like proteins, and mammalian Fibulin-1 is most 
similar to C. elegans FBL-1 (Timpl et al., 2003). For example, 
Fibulin-1 and FBL-1 have the same types of motifs in the same 
number, and both have alternatively spliced FIBC and FIBD 
domains. However, unlike C. elegans FBL-1, the EGF domain 
of mammalian Fibulin-1 is not alternatively spliced; it contains 
the same EGF repeats in both C and D isoforms (Argraves et al., 
1990). In contrast, mammalian Fibulin-2 and -3 are subject to 
alternative splicing within their EGF domains (Lecka-Czernik 
et al., 1995; Grassel et al., 1999). The functions of the alterna-
tively spliced EGF repeats in these other fi  bulins have not been 
explored, but our fi  ndings suggest the possibility that they may 
have signaling activity. Perhaps the single C. elegans fbl-1 gene 
encompasses features that have been distributed to multiple fi  b-
ulin genes in mammals.
Figure 5.  EGF2C and FIBC domains are redundant signals 
for localization to pharyngeal basal lamina. (left and middle) 
Heads of fbl-1(q771) L4 larvae; transgenes are noted in the 
ﬁ  gure. Arrowheads indicate pharyngeal basal lamina; ante-
rior to the left. Arrows indicate ﬂ  uorescence from the coinjec-
tion marker. Bars, 20 μm. (left) 0.8-μm confocal slices. 
(middle) Differential interference contrast image of the same 
animal. (A, F, L, O, and R) Constructs with either EGF2C or 
FIBC localize to pharyngeal basal lamina. (I) VENUS::FBL-1D 
not in pharyngeal basal lamina. (right) Anti-VENUS Western 
blots. Both full-length FBL-1 isoforms are predicted to migrate 
at  100 kD, but FBL-1D only accumulates an  50-kD degra-
dation product. TG, extract from transgenic strain noted in the 
left column; WT, extract from wild-type animals not carrying 
transgene; VF, extract from animals carrying VENUS::FBL-1; 
Act, actin loading control. Arrows mark the predicted sizes of 
transgenic proteins. Arrowheads mark abundant degrada-
tion products.JCB • VOLUME 175 • NUMBER 2 • 2006  222
Materials and methods
Nematode analysis
All strains were derivatives of wild-type Bristol strain N2 and were 
maintained at 20°C.  fbl-1(q771) was made by standard methods 
(Kraemer et al., 1999); fbl-1(q771) removes F56H11::15,541 through 
F56H11::16,223. The fbl-1(tk45) deletion introduces a stop codon after 
the ﬁ  rst EGF repeat (Kubota et al., 2004). Other strains include fbl-1(q750) 
(Hesselson et al., 2004), gon-1(q518) (Blelloch and Kimble, 1999), 
mig-17(k174) (Nishiwaki et al., 2000), and nid-1(cg119) (Kang and 
Kramer, 2000).
fbl-1 transcript analysis
Total RNA was extracted from 50 L4s of each genotype. We performed 
37 cycles of RT-PCR at 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s 
  using forward 5′-G  A  T  T  C  G  A  C  T  T  G  G  C  A  C  C  A  G  -3′ and reverse 5′-G  A  A  T  G  A-
T  C  C  A  G  G  G  G  T  G  T  T  C  -3′ primers. eft-3 was ampliﬁ  ed from each sample as 
a positive control.
Transgenes
Fragments of genomic fbl-1 were fused to VENUS under the control of 
the  fbl-1 promoter and injected at 5 ng/μl with either neuronal coin-
jection marker ttx-3::dsRED or rol-6(gf) at 20 ng/μl. See supplemental 
methods for construct details (available at http://www.jcb.org/cgi/
content/full/jcb.200608061/DC1).
FBL-1 localization
VENUS::FBL-1 localization was assayed in fbl-1(q771) mutants, which 
lack endogenous FBL-1 protein. Images were obtained on a confocal 
  microscope (LSM510; Carl Zeiss MicroImaging, Inc.) with a 63× NA 
1.4 objective lens. The brightness of images was uniformly modiﬁ  ed  in 
Photoshop (Adobe).
Western blots
Extract prepared from 20 transgenic L4s was loaded per lane. Proteins 
were separated on 4–20% gradient gels (Cambrex). Blots were probed 
with JL-8 anti-GFP antibody at 1:1,000 (Stratagene) and detected with an 
HRP-conjugated secondary antibody at 1:40,000 (Jackson Immuno-
Research Laboratories). Each blot was reprobed with an anti-actin anti-
body as a loading control.
Phenotype characterization
Embryonic lethality. Embryonic lethality was assessed by scoring dead em-
bryos among an entire brood from a single fbl-1(q771) gon-1(0) 
hermaphrodite.
Staging larval arrest. 20 synchronized fbl-1(q771) gon-1(0) L1s 
were grown for 24 h and scored for L1-speciﬁ  c alae; all had exited the 
L1 stage. Mixed stage fbl-1(q771) gon-1(0) double mutants were ﬁ  xed and 
stained with MH27, a monoclonal antibody that highlights junctions and 
permits visualization of vulval precursor morphology. Most had undivided 
vulval precursors showing a failure to progress through the L3 stage.
Pharyngeal function. Pharyngeal contraction rates were counted in 
both wild-type and fbl-1(q771) gon-1(0) double mutants at hatching and at 
48 h after hatching.
Gut function. Larvae were fed a mixture of OP50 bacteria and ﬂ  uo-
rescently labeled beads (Bangs Beads). After 1 h, they were moved to a 
plate with only OP50, and, after 5 min, they were mounted. Beads were 
visualized by ﬂ  uorescence microscopy.
Rescue assays
Larval arrest. Animals were synchronized by hatching in M9 and incu-
bated for at least 144 h. Adulthood was determined by vulval morphology. 
Wild-type animals reach adulthood within 52 h. If transgenic double 
  mutants did not reach adulthood within 144 h, they were scored as not 
rescued. For each strain, 25 animals were scored.
Length of larval development. Animals were placed singly on plates, 
and time to mid-L4 was scored by vulval morphology. For each strain, 25 
animals were scored.
Adult body size. L4s were grown for 24 h and measured for size by 
multiplying length and width to obtain area as a rough estimate of organ-
ism size. For each strain, 10 animals were scored.
Gonadal width. Mid-L4s were scored as rescued if the proximal go-
nadal arm spanned less than two thirds of the width of the body cavity. For 
each strain, 20 animals were scored.
Sterility. Mid-L4s were grown for 48 h and scored for embryo 
  production. For each strain, 20 animals were scored.
Image acquisition
Nomarski micrographs were obtained on a microscope (Imager.D1; Carl 
Zeiss MicroImaging, Inc.) with either a 63× NA 1.4 or 10× NA 0.3 
  objective lens. Images were captured in Openlab 4.0.4 (Improvision) with 
a camera (C4742-95; Hamamatsu).
Online supplemental material
Fig. S1 shows confocal localization and Western blots for transgenes 
that are not depicted in Fig. 5. Supplemental methods provide infor-
mation on plasmids, extrachromosomal arrays, and strains used in this 
study. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200608061/DC1.
We thank Dana Byrd, Mike Chesney, Stephanie Hesselson, and Bryan Phillips 
for comments on the manuscript.
D. Hesselson is supported by the Canadian Institutes of Health   Research. 
J. Kimble is supported by the National Institutes of Health and is an investigator 
of the Howard Hughes Medical Institute.
Submitted: 9 August 2006
Accepted: 19 September 2006
References
Argraves, W.S., H. Tran, W.H. Burgess, and K. Dickerson. 1990. Fibulin is an ex-
tracellular matrix and plasma glycoprotein with repeated domain structure. 
J. Cell Biol. 111:3155–3164.
Barth, J.L., K.M. Argraves, E.F. Roark, C.D. Little, and W.S. Argraves. 1998. 
Identifi  cation of chicken and C. elegans fi  bulin-1 homologs and charac-
terization of the C. elegans fi  bulin-1 gene. Matrix Biol. 17:635–646.
Blelloch, R., and J. Kimble. 1999. Control of organ shape by a secreted 
metalloprotease in the nematode Caenorhabditis elegans.  Nature. 
399:586–590.
Debeer, P., E.F. Schoenmakers, W.O. Twal, W.S. Argraves, L. De Smet, J.P. 
Fryns, and W.J. Van De Ven. 2002. The fi  bulin-1 gene (FBLN1) is dis-
rupted in a t(12;22) associated with a complex type of synpolydactyly. 
J. Med. Genet. 39:98–104.
Giannelli, G., J. Falk-Marzillier, O. Schiraldi, W.G. Stetler-Stevenson, and V. 
Quaranta. 1997. Induction of cell migration by matrix metalloprotease-2 
cleavage of laminin-5. Science. 277:225–228.
Grassel, S., F.X. Sicot, S. Gotta, and M.L. Chu. 1999. Mouse fi  bulin-2 gene. 
Complete exon-intron organization and promoter characterization. Eur. 
J. Biochem. 263:471–477.
Hesselson, D., C. Newman, K.W. Kim, and J. Kimble. 2004. GON-1 and 
fi  bulin have antagonistic roles in control of organ shape. Curr. Biol. 
14:2005–2010.
Kang, S.H., and J.M. Kramer. 2000. Nidogen is nonessential and not required 
for normal type IV collagen localization in Caenorhabditis elegans. Mol. 
Biol. Cell. 11:3911–3923.
Kirkpatrick, C.A., B.D. Dimitroff, J.M. Rawson, and S.B. Selleck. 2004. Spatial 
regulation of Wingless morphogen distribution and signaling by Dally-
like protein. Dev. Cell. 7:513–523.
Kohl, J. 2001. Anaphylatoxins and infectious and non-infectious infl  ammatory 
diseases. Mol. Immunol. 38:175–187.
Kostka, G., R. Giltay, W. Bloch, K. Addicks, R. Timpl, R. Fassler, and M.L. 
Chu. 2001. Perinatal lethality and endothelial cell abnormalities in sev-
eral vessel compartments of fi  bulin-1-defi  cient mice. Mol. Cell. Biol. 
21:7025–7034.
Kraemer, B., S. Crittenden, M. Gallegos, G. Moulder, R. Barstead, J. Kimble, 
and M. Wickens. 1999. NANOS-3 and FBF proteins physically interact 
to control the sperm-oocyte switch in Caenorhabditis elegans. Curr. Biol. 
9:1009–1018.
Kreuger, J., L. Perez, A.J. Giraldez, and S.M. Cohen. 2004. Opposing activi-
ties of Dally-like glypican at high and low levels of Wingless morphogen 
 activity.  Dev. Cell. 7:503–512.
Kubota, Y., R. Kuroki, and K. Nishiwaki. 2004. A fi  bulin-1 homolog interacts 
with an ADAM protease that controls cell migration in C. elegans. Curr. 
Biol. 14:2011–2018.
Lecka-Czernik, B., C.K. Lumpkin Jr., and S. Goldstein. 1995. An overexpressed 
gene transcript in senescent and quiescent human fi  broblasts encoding 
a novel protein in the epidermal growth factor-like repeat family stimu-
lates DNA synthesis. Mol. Cell. Biol. 15:120–128.GROWTH CONTROL BY FIBULIN EGF REPEATS • HESSELSON AND KIMBLE 223
Massague, J. 1983. Epidermal growth factor-like transforming growth factor. 
I. Isolation, chemical characterization, and potentiation by other trans-
forming factors from feline sarcoma virus-transformed rat cells. J. Biol. 
Chem. 258:13606–13613.
Muriel, J.M., C. Dong, H. Hutter, and B.E. Vogel. 2005. Fibulin-1C and Fibulin-
1D splice variants have distinct functions and assemble in a hemicentin-
dependent manner. Development. 132:4223–4234.
Muriel, J.M., X. Xu, J.M. Kramer, and B.E. Vogel. 2006. Selective assembly 
of fi  bulin-1 splice variants reveals distinct extracellular matrix networks 
and novel functions for perlecan/UNC-52 splice variants. Dev. Dyn. 
235:2632–2640.
Nikolova, G., N. Jabs, I. Konstantinova, A. Domogatskaya, K. Tryggvason, L. 
Sorokin, R. Fassler, G. Gu, H.P. Gerber, N. Ferrara, et al. 2006. The vas-
cular basement membrane: a niche for insulin gene expression and Beta 
cell proliferation. Dev. Cell. 10:397–405.
Nishiwaki, K., N. Hisamoto, and K. Matsumoto. 2000. A metalloprotease dis-
integrin that controls cell migration in Caenorhabditis elegans. Science. 
288:2205–2208.
Prigent, S.A., and N.R. Lemoine. 1992. The type 1 (EGFR-related) family of 
growth factor receptors and their ligands. Prog. Growth Factor Res. 
4:1–24.
Qing, J., V.M. Maher, H. Tran, W.S. Argraves, R.W. Dunstan, and J.J. McCormick. 
1997. Suppression of anchorage-independent growth and matrigel inva-
sion and delayed tumor formation by elevated expression of fi  bulin-1D in 
human fi  brosarcoma-derived cell lines. Oncogene. 15:2159–2168.
Sasaki, T., G. Kostka, W. Gohring, H. Wiedemann, K. Mann, M.L. Chu, and R. 
Timpl. 1995. Structural characterization of two variants of fi  bulin-1 that 
differ in nidogen affi  nity. J. Mol. Biol. 245:241–250.
Timpl, R., T. Sasaki, G. Kostka, and M.L. Chu. 2003. Fibulins: a versatile family 
of extracellular matrix proteins. Nat. Rev. Mol. Cell Biol. 4:479–489.
Tran, H., W.J. VanDusen, and W.S. Argraves. 1997. The self-association and 
fi  bronectin-binding sites of fi  bulin-1 map to calcium-binding epidermal 
growth factor-like domains. J. Biol. Chem. 272:22600–22606.